Versant Venture Management, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 57 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Versant Venture Management, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q2 2024$2,200,435
-76.0%
3,561,1500.0%2.85%
-67.9%
Q1 2024$9,152,156
+26.0%
3,561,1500.0%8.87%
+375.1%
Q4 2023$7,264,746
+18.6%
3,561,1500.0%1.87%
-42.6%
Q3 2023$6,125,178
-11.8%
3,561,1500.0%3.26%
-60.5%
Q2 2023$6,944,243
-29.9%
3,561,1500.0%8.24%
-60.1%
Q1 2023$9,899,997
-19.4%
3,561,1500.0%20.64%
-18.8%
Q4 2022$12,285,968
+34.2%
3,561,1500.0%25.42%
+62.9%
Q3 2022$9,152,000
+6.2%
3,561,1500.0%15.60%
+18.1%
Q2 2022$8,618,000
-41.3%
3,561,1500.0%13.21%
-9.8%
Q1 2022$14,672,000
-68.0%
3,561,1500.0%14.65%
-40.2%
Q4 2021$45,796,000
+5.9%
3,561,150
-11.1%
24.49%
+36.7%
Q3 2021$43,264,000
+6.5%
4,005,894
-10.0%
17.91%
+33.1%
Q2 2021$40,634,000
-3.2%
4,450,6380.0%13.46%
+64.7%
Q1 2021$41,970,000
+139.3%
4,450,6380.0%8.18%
+349.0%
Q4 2020$17,536,000
+113.3%
4,450,638
+43.4%
1.82%
+21.0%
Q3 2020$8,223,000
-100.0%
3,102,9290.0%1.50%
-49.2%
Q2 2020$20,603,449,000
+14.1%
3,102,9290.0%2.96%
-40.2%
Q1 2020$18,059,047,000
-35.1%
3,102,9290.0%4.95%
-40.9%
Q4 2019$27,833,273,000
+3.9%
3,102,9290.0%8.39%
-19.1%
Q3 2019$26,793,792,000
-22.5%
3,102,9290.0%10.37%
+2.9%
Q2 2019$34,566,629,0003,102,92910.07%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,005,894$43,264,00017.91%
FRAZIER MANAGEMENT LLC 4,667,242$50,406,0004.03%
EcoR1 Capital, LLC 5,560,748$60,056,0002.09%
Palo Alto Investors LP 2,356,282$25,448,0001.54%
Avidity Partners Management LP 4,457,831$48,145,0001.07%
BVF INC/IL 1,528,072$16,503,0000.64%
Redmile Group, LLC 2,821,085$30,468,0000.53%
ACT CAPITAL MANAGEMENT, LLC 74,000$799,0000.41%
DG Capital Management, LLC 83,162$898,0000.18%
HighVista Strategies LLC 14,453$156,0000.10%
View complete list of GRITSTONE ONCOLOGY INC shareholders